Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Oct. 17)
Listen now
Description
In this week’s View, Dr. Eagle discusses the TIME Study, a prospective, randomized, open-labe,l blinded-endpoint clinical trial exploring cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives, then looks at phenotyping the hypertensive heart. Finally, Dr. Eagle takes a look at a multinational study on programmed ventricular stimulation as an additional primary prevention risk stratification tool in arrhythmogenic right ventricular cardiomyopathy. Subscribe to Eagle’s Eye View
More Episodes
In this week’s View, Dr. Eagle looks at a scientific statement from the American Heart Association on the diagnosis and management of cardiac sarcoidosis. He then examines the temporal trends and clinical implications of ischemic stroke in women with atrial fibrillation. Finally, Dr. Eagle shares...
Published 04/24/24
In this week’s View, Dr. Eagle looks at a systematic review and meta-analysis of antibiotic prophylaxis and infective endocarditis incidence following invasive dental procedures. He then examines the issue of serious bleeding in patients with atrial fibrillation using diltiazem with apixaban or...
Published 04/17/24